Carlsmed Shares Jump 23% After Higher Third-Quarter Revenue, Raised Guidance
Carlsmed reported third-quarter revenue above the year-earlier level and raised its 2026 revenue guidance. Shares traded 23% higher at $18.13, after reaching a session 52-week high of $18.24.
By Chris WackCarlsmed shares rose after the company reported third-quarter revenue that was higher than last year, and raised 2026 revenue guidance.The stock was 23% higher, at $18.13, in midday trading, after hitting its 52-week high of $18.24 earlier in the session.The medical technology company…